129 related articles for article (PubMed ID: 30674871)
1. Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect.
Zhang Q; Qin Y; Zhao J; Tang Y; Hu X; Zhong W; Li M; Zong S; Li M; Tao H; Zhang Z; Chen S; Liu H; Yang L; Zhou H; Liu Y; Sun T; Yang C
Cell Death Dis; 2019 Jan; 10(2):43. PubMed ID: 30674871
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
3. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
Jue C; Lin C; Zhisheng Z; Yayun Q; Feng J; Min Z; Haibo W; Youyang S; Hisamitsu T; Shintaro I; Shiyu G; Yanqing L
Oncotarget; 2017 Jan; 8(2):2501-2513. PubMed ID: 27705934
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma.
Xiao T; Zhang Q; Zong S; Zhong WL; Qin Y; Bi Z; Chen S; Liu HJ; Wei JJ; Zhou BJ; Wang LM; Zhou HG; Liu YR; Sun T; Yang C
J Exp Clin Cancer Res; 2018 Aug; 37(1):185. PubMed ID: 30081924
[TBL] [Abstract][Full Text] [Related]
5. Thymidine phosphorylase promotes metastasis and serves as a marker of poor prognosis in hepatocellular carcinoma.
Zhang Q; Zhang Y; Hu X; Qin Y; Zhong W; Meng J; Xiao T; Zhang C; Li M; Chen S; Liu H; Liu Y; Sun T; Yang C
Lab Invest; 2017 Aug; 97(8):903-912. PubMed ID: 28530649
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
[TBL] [Abstract][Full Text] [Related]
7. The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.
Cao Z; Sun B; Zhao X; Zhang Y; Gu Q; Liang X; Dong X; Zhao N
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264434
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
Zhao X; Sun B; Liu T; Shao B; Sun R; Zhu D; Zhang Y; Gu Q; Dong X; Liu F; Zhao N; Zhang D; Li Y; Meng J; Gong W; Zheng Y; Zheng X
Cancer Sci; 2018 Oct; 109(10):3197-3208. PubMed ID: 30022558
[TBL] [Abstract][Full Text] [Related]
9. Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.
Meng J; Chen S; Lei YY; Han JX; Zhong WL; Wang XR; Liu YR; Gao WF; Zhang Q; Tan Q; Liu HJ; Zhou HG; Sun T; Yang C
Oncogene; 2019 Jan; 38(2):228-243. PubMed ID: 30087438
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma.
Dong F; Li R; Wang J; Zhang Y; Yao J; Jiang SH; Hu X; Feng M; Bao Z
J Exp Clin Cancer Res; 2021 Apr; 40(1):121. PubMed ID: 33832535
[TBL] [Abstract][Full Text] [Related]
11. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma.
Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Liu T; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
Int J Mol Med; 2015 Sep; 36(3):783-91. PubMed ID: 26202447
[TBL] [Abstract][Full Text] [Related]
13. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
[TBL] [Abstract][Full Text] [Related]
14. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma.
Yang J; Lu Y; Lin YY; Zheng ZY; Fang JH; He S; Zhuang SM
Cancer Lett; 2016 Dec; 383(1):18-27. PubMed ID: 27693460
[TBL] [Abstract][Full Text] [Related]
15. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.
Shao B; Zhao X; Liu T; Zhang Y; Sun R; Dong X; Liu F; Zhao N; Zhang D; Wu L; Wang Y; Wang M; Meng J; Lin X; Sun B
J Cell Mol Med; 2019 Feb; 23(2):1363-1374. PubMed ID: 30506621
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2/Twist1 cooperation.
Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
Exp Mol Pathol; 2015 Oct; 99(2):383-91. PubMed ID: 26318343
[TBL] [Abstract][Full Text] [Related]
17. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
[TBL] [Abstract][Full Text] [Related]
18. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.
Ou H; Chen Z; Xiang L; Fang Y; Xu Y; Liu Q; Hu Z; Li X; Huang Y; Yang D
Cancer Sci; 2019 Apr; 110(4):1169-1182. PubMed ID: 30677195
[TBL] [Abstract][Full Text] [Related]
19. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
20. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer.
Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
Oncol Rep; 2004 Aug; 12(2):347-51. PubMed ID: 15254700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
